| TRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | diffuse large B-cell lymphoma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | lymphoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 2.0 | Withdrawn | ClinicalTrials |
| ISOTRETINOIN | Small molecule | COVID-19 | Retinoic acid receptor agonist | 4.0 | Not yet recruiting | ClinicalTrials |
| TAMIBAROTENE | Small molecule | pancreatic carcinoma | Retinoic acid receptor alpha agonist | 1.0 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | prostate adenocarcinoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis vulgaris | Retinoid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | chronic myelogenous leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Active, not recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | myeloproliferative disorder | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | lung cancer | Retinoic acid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| NRX195183 | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor alpha agonist | 2.0 | Withdrawn | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 0.5 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | childhood acute lymphoblastic leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | multiple myeloma | Retinoic acid receptor agonist | 1.0 | Active, not recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | tuberculosis | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | emphysema | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | glioblastoma multiforme | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 0.5 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | azoospermia | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | grade III glioma | Retinoic acid receptor agonist | 1.0 | Active, not recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neoplasm | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis vulgaris | Retinoic acid receptor agonist | 4.0 | - | DailyMed |
| TAZAROTENE | Small molecule | acne | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TAMIBAROTENE | Small molecule | tropical spastic paraparesis | Retinoic acid receptor alpha agonist | 2.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | lentigo | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | multiple myeloma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | breast neoplasm | Retinoic acid receptor agonist | 2.0 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | rosacea | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | lentigo | Retinoic acid receptor agonist | 4.0 | - | DailyMed |
| ISOTRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 2.0 | Withdrawn | ClinicalTrials |
| ISOTRETINOIN | Small molecule | cervical cancer | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | hematopoietic and lymphoid cell neoplasm | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | central centrifugal cicatricial alopecia | Retinoic acid receptor agonist | 0.5 | Enrolling by invitation | ClinicalTrials |
| ISOTRETINOIN | Small molecule | childhood acute myeloid leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | - | DailyMed,ATC |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 4.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 1.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | lung cancer | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | oligodendroglioma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ACITRETIN | Small molecule | HIV infection | Retinoid receptor agonist | 1.0 | Withdrawn | ClinicalTrials |
| ISOTRETINOIN | Small molecule | rosacea | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | renal cell carcinoma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 1.0 | Withdrawn | ClinicalTrials |
| ISOTRETINOIN | Small molecule | medulloblastoma | Retinoic acid receptor agonist | 3.0 | Active, not recruiting | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 1.0 | Recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Juvenile Myelomonocytic Leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | anaplastic oligodendroglioma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ALITRETINOIN | Small molecule | Eczema | Retinoid receptor agonist | 3.0 | Recruiting | ClinicalTrials |
| TAMIBAROTENE | Small molecule | Crohn's disease | Retinoic acid receptor alpha agonist | 2.0 | Completed | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ALITRETINOIN | Small molecule | Eczema | Retinoid receptor agonist | 3.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 1.0 | Active, not recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | neoplasm | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | actinic keratosis | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | seborrheic dermatitis | Retinoic acid receptor agonist | 4.0 | Unknown status | ClinicalTrials |
| TAZAROTENE | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | - | DailyMed |
| TRETINOIN | Small molecule | autoimmune thrombocytopenic purpura | Retinoic acid receptor agonist | 3.0 | Withdrawn | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 3.0 | Withdrawn | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 4.0 | Not yet recruiting | ClinicalTrials |
| ADAPALENE | Small molecule | plantar wart | Retinoic acid receptor agonist | 0.5 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | dysplasia of cervix | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | kidney cancer | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | multiple myeloma | Retinoic acid receptor agonist | 2.0 | Recruiting | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 0.5 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | - | DailyMed,ATC |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 3.0 | Active, not recruiting | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis vulgaris | Retinoid receptor agonist | 4.0 | Active, not recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 0.5 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Wilms tumor | Retinoic acid receptor agonist | 1.0 | Not yet recruiting | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | ganglioneuroblastoma | Retinoic acid receptor agonist | 3.0 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | melanoma | Retinoic acid receptor agonist | 2.0 | Active, not recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ETRETINATE | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | - | ATC |
| TRETINOIN | Small molecule | sclerosing cholangitis | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | non-small cell lung carcinoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 2.0 | Active, not recruiting | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | Not yet recruiting | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 2.0 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | basal cell carcinoma | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 3.0 | Active, not recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 2.0 | Recruiting | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | neoplastic syndrome | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | - | DailyMed,ATC |
| ISOTRETINOIN | Small molecule | gliosarcoma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ACITRETIN | Small molecule | dermatitis | Retinoid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ALITRETINOIN | Small molecule | atopic eczema | Retinoid receptor agonist | 4.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | infection | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ADAPALENE | Small molecule | skin disease | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | emphysema | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 1.0 | Recruiting | ClinicalTrials |
| ALITRETINOIN | Small molecule | hand dermatosis | Retinoid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | lymphoma | Retinoic acid receptor agonist | 2.0 | Withdrawn | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Burkitts lymphoma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | multiple myeloma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Unknown status | ClinicalTrials |
| ACITRETIN | Small molecule | Alzheimer disease | Retinoid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | HIV-1 infection | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 4.0 | Recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | ganglioneuroblastoma | Retinoic acid receptor agonist | 2.0 | Active, not recruiting | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 4.0 | - | DailyMed,ATC |
| ADAPALENE | Small molecule | molluscum contagiosum | Retinoic acid receptor agonist | 3.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | multiple myeloma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 2.0 | Active, not recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | non-small cell lung carcinoma | Retinoic acid receptor agonist | 1.0 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | lung cancer | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | pancreatic carcinoma | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | autoimmune thrombocytopenia | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | pancreatic adenocarcinoma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 1.0 | Withdrawn | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 3.0 | Unknown status | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 3.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | freckles | Retinoic acid receptor agonist | 4.0 | - | DailyMed |
| TRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ALITRETINOIN | Small molecule | tuberculosis | Retinoid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| TAMIBAROTENE | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor alpha agonist | 1.0 | Terminated | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | - | ATC |
| TRETINOIN | Small molecule | Striae distensae | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | non-small cell lung carcinoma | Retinoic acid receptor agonist | 3.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | freckles | Retinoic acid receptor agonist | 4.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 3.0 | Withdrawn | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | Active, not recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | prostate cancer | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| ALITRETINOIN | Small molecule | breast cancer | Retinoid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 2.0 | Recruiting | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | breast cancer | Retinoic acid receptor agonist | 3.0 | Not yet recruiting | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | Recruiting | ClinicalTrials |
| TAZAROTENE | Small molecule | acne | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | anti-neutrophil antibody associated vasculitis | Retinoic acid receptor agonist | 2.0 | Withdrawn | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 1.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | head and neck malignant neoplasia | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | brain neoplasm | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | melanoma | Retinoic acid receptor agonist | 1.0 | Active, not recruiting | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 3.0 | Not yet recruiting | ClinicalTrials |
| ALITRETINOIN | Small molecule | neoplasm | Retinoid receptor agonist | 4.0 | - | ATC |
| TRETINOIN | Small molecule | small cell lung carcinoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ALITRETINOIN | Small molecule | cutaneous lupus erythematosus | Retinoid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | freckles | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | Genetic hypopigmentation of the skin | Retinoic acid receptor agonist | 4.0 | - | DailyMed |
| TAMIBAROTENE | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor alpha agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | autoimmune thrombocytopenic purpura | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Central Nervous System Neoplasm | Retinoic acid receptor agonist | 3.0 | Withdrawn | ClinicalTrials |
| TAMIBAROTENE | Small molecule | myelodysplastic syndrome | Retinoic acid receptor alpha agonist | 2.0 | Active, not recruiting | ClinicalTrials |
| TAZAROTENE | Small molecule | psoriasis | Retinoic acid receptor agonist | 4.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | freckles | Retinoic acid receptor agonist | 2.0 | Suspended | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | Withdrawn | ClinicalTrials |
| TRETINOIN | Small molecule | amyotrophic lateral sclerosis | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 1.0 | Recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Klinefelter's syndrome | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | mycosis fungoides | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ACITRETIN | Small molecule | squamous cell carcinoma | Retinoid receptor agonist | 4.0 | Withdrawn | ClinicalTrials |
| TRETINOIN | Small molecule | freckles | Retinoic acid receptor agonist | 0.5 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | prostate cancer | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 3.0 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 4.0 | - | DailyMed |
| TRETINOIN | Small molecule | adenoid cystic carcinoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | glioblastoma multiforme | Retinoic acid receptor agonist | 1.0 | Active, not recruiting | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 0.5 | Not yet recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | mixed glioma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Terminated | ClinicalTrials |
| ADAPALENE | Small molecule | inflammation | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | rosacea | Retinoic acid receptor agonist | 3.0 | Terminated | ClinicalTrials |
| ADAPALENE | Small molecule | acne | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | acne | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | epidermolysis bullosa | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | ichthyosis | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | autism | Retinoic acid receptor agonist | 0.5 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | actinic keratosis | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | tuberculosis | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | COVID-19 | Retinoic acid receptor agonist | 1.0 | Not yet recruiting | ClinicalTrials |
| TAMIBAROTENE | Small molecule | myelodysplastic syndrome | Retinoic acid receptor alpha agonist | 3.0 | Recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | lung cancer | Retinoic acid receptor agonist | 3.0 | Withdrawn | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ACITRETIN | Small molecule | skin disease | Retinoid receptor agonist | 4.0 | Withdrawn | ClinicalTrials |
| TAMIBAROTENE | Small molecule | Alzheimer disease | Retinoic acid receptor alpha agonist | 2.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | autoimmune thrombocytopenic purpura | Retinoic acid receptor agonist | 2.0 | Active, not recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Juvenile Myelomonocytic Leukemia | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | kidney cancer | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ACITRETIN | Small molecule | melanoma | Retinoid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| TAMIBAROTENE | Small molecule | lupus nephritis | Retinoic acid receptor alpha agonist | 2.0 | Unknown status | ClinicalTrials |
| ALITRETINOIN | Small molecule | Eczema | Retinoid receptor agonist | 4.0 | - | ATC |
| TRETINOIN | Small molecule | anemia | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | kidney cancer | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | Cutaneous T-cell lymphoma | Retinoic acid receptor agonist | 1.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | COVID-19 | Retinoic acid receptor agonist | 3.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | Striae distensae | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | autoimmune thrombocytopenic purpura | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic/myeloproliferative disease | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | acne | Retinoic acid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 1.0 | Active, not recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | neoplasm | Retinoic acid receptor agonist | 4.0 | - | ATC |
| TAZAROTENE | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ALITRETINOIN | Small molecule | Eczema | Retinoid receptor agonist | 3.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | COVID-19 | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis vulgaris | Retinoid receptor agonist | 4.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | breast cancer | Retinoic acid receptor agonist | 3.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | Hypercholesterolemia | Retinoic acid receptor agonist | 0.5 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Hodgkins lymphoma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TAMIBAROTENE | Small molecule | acute myeloid leukemia | Retinoic acid receptor alpha agonist | 2.0 | Active, not recruiting | ClinicalTrials |
| TAMIBAROTENE | Small molecule | acute myeloid leukemia | Retinoic acid receptor alpha agonist | 2.0 | Recruiting | ClinicalTrials |
| ALITRETINOIN | Small molecule | lichen planus | Retinoid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | melanoma | Retinoic acid receptor agonist | 1.0 | Recruiting | ClinicalTrials |
| TAZAROTENE | Small molecule | skin disease | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | squamous cell carcinoma | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | COVID-19 | Retinoic acid receptor agonist | 2.0 | Not yet recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | lymphoblastic lymphoma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | cutaneous melanoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 1.0 | Recruiting | ClinicalTrials |
| TRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 2.0 | Terminated | ClinicalTrials |
| TRETINOIN | Small molecule | sclerosing cholangitis | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neoplasm | Retinoic acid receptor agonist | 1.0 | Recruiting | ClinicalTrials |
| ISOTRETINOIN | Small molecule | medulloblastoma | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| ALITRETINOIN | Small molecule | psoriasis | Retinoid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | tinea pedis | Retinoic acid receptor agonist | 2.0 | Unknown status | ClinicalTrials |
| ACITRETIN | Small molecule | psoriasis | Retinoid receptor agonist | 4.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | Alzheimer disease | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| ISOTRETINOIN | Small molecule | focal segmental glomerulosclerosis | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute promyelocytic leukemia | Retinoic acid receptor agonist | 3.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | leukemia | Retinoic acid receptor agonist | 3.0 | Unknown status | ClinicalTrials |
| ISOTRETINOIN | Small molecule | anaplastic astrocytoma | Retinoic acid receptor agonist | 1.0 | Terminated | ClinicalTrials |
| TAZAROTENE | Small molecule | acne | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | proliferative vitreoretinopathy | Retinoic acid receptor agonist | 4.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TRETINOIN | Small molecule | acute myeloid leukemia | Retinoic acid receptor agonist | 1.0 | Unknown status | ClinicalTrials |
| TRETINOIN | Small molecule | myelodysplastic syndrome | Retinoic acid receptor agonist | 1.0 | Completed | ClinicalTrials |
| TAZAROTENE | Small molecule | skin carcinoma | Retinoic acid receptor agonist | 2.0 | Completed | ClinicalTrials |
| ISOTRETINOIN | Small molecule | neuroblastoma | Retinoic acid receptor agonist | 3.0 | Recruiting | ClinicalTrials |